Filana Therapeutics (MEX:FLNA) Cyclically Adjusted FCF per Share: MXN-23.96 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLNA Filana Therapeutics Inc MEX:FLNA
32 GF Score
Price MXN23.00
! 2 Warning Signs
View Full Analysis

What is Filana Therapeutics Cyclically Adjusted FCF per Share?

Filana Therapeutics MEX:FLNA 32 Cyclically Adjusted FCF per Share is MXN-23.96 as of Mar. 2026. GuruFocus rates MEX:FLNA with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Filana Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-3.314. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-23.96 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -7.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Filana Therapeutics was 2.00% per year. The lowest was -16.10% per year. And the median was -8.25% per year.

As of today (2026-07-22), Filana Therapeutics's current stock price is MXN23.00. Filana Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN-23.96. Filana Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Filana Therapeutics  (MEX:FLNA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Filana Therapeutics Cyclically Adjusted FCF per Share Related Terms


Filana Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Filana Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Filana Therapeutics Cyclically Adjusted FCF per Share Chart

Filana Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.03 -27.26 -33.23 -36.75 -39.03

Filana Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -56.37 -32.27 -20.78 -39.03 -23.96

MEX:FLNA vs BOLD, INKT, XLO: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Filana Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filana Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Filana Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Filana Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


MEX:FLNA
32GF Score
Filana Therapeutics Inc MEX:FLNA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Filana Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-3.314/330.2130*330.2130
=-3.314

Current CPI (Mar. 2026) = 330.2130.

Filana Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -9.272 241.018 -12.703
201609 -8.246 241.428 -11.278
201612 -9.562 241.432 -13.078
201703 -4.184 243.801 -5.667
201706 -8.840 244.955 -11.917
201709 -5.971 246.819 -7.988
201712 -4.317 246.524 -5.783
201803 -4.497 249.554 -5.950
201806 -3.236 251.989 -4.241
201809 -2.246 252.439 -2.938
201812 -0.644 251.233 -0.846
201903 -0.703 254.202 -0.913
201906 -0.661 256.143 -0.852
201909 -0.840 256.759 -1.080
201912 -0.612 256.974 -0.786
202003 -1.144 258.115 -1.464
202006 -0.784 257.797 -1.004
202009 -1.921 260.280 -2.437
202012 -0.774 260.474 -0.981
202103 -1.250 264.877 -1.558
202106 -2.560 271.696 -3.111
202109 -7.598 274.310 -9.146
202112 -4.100 278.802 -4.856
202203 -11.936 287.504 -13.709
202206 -6.325 296.311 -7.049
202209 -11.404 296.808 -12.687
202212 -10.032 296.797 -11.161
202303 -5.878 301.836 -6.431
202306 -8.171 305.109 -8.843
202309 -11.012 307.789 -11.814
202312 -8.994 306.746 -9.682
202403 -7.198 312.332 -7.610
202406 -7.233 314.175 -7.602
202409 -7.509 315.301 -7.864
202412 -26.556 315.605 -27.785
202503 -4.805 319.799 -4.961
202506 -1.928 322.561 -1.974
202509 -2.362 324.800 -2.401
202512 -3.633 324.054 -3.702
202603 -3.314 330.213 -3.314

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-23.96 mean?
Filana Therapeutics (MEX:FLNA) has a Cyclically Adjusted FCF per Share of MXN-23.96 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Filana Therapeutics and its competitors.
Is Filana Therapeutics' Cyclically Adjusted FCF per Share too high?
Filana Therapeutics' current Cyclically Adjusted FCF per Share is MXN-23.96. Overall, Filana Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Filana Therapeutics' Cyclically Adjusted FCF per Share compare to BOLD and INKT?
Filana Therapeutics' Cyclically Adjusted FCF per Share of MXN-23.96 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Filana Therapeutics and its competitors. Filana Therapeutics's current Cyclically Adjusted FCF per Share is MXN-23.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Filana Therapeutics stock overvalued right now?
Filana Therapeutics (MEX:FLNA) has a current Cyclically Adjusted FCF per Share of MXN-23.96. The current Cyclically Adjusted FCF per Share is MXN-23.96. Filana Therapeutics' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Filana Therapeutics (MEX:FLNA), the current Cyclically Adjusted FCF per Share is MXN-23.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Filana Therapeutics Business Description

Other Exchanges FLNA:USAPX91:Germany
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
32GF Score

Get the complete analysis for MEX:FLNA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN23.00
Price